Silicone breast implant provider Sientra has entered into a services agreement with Vesta, a Lubrizol LifeSciences company and contract manufacturer of silicone products and other medical devices.
Under terms of the agreement, Vesta will establish manufacturing capacity for Sientra and is working with the company to finalize a long-term supply arrangement for its PMA-approved breast implants. Sientra expects to submit a PMA Supplement to the FDA during the first quarter of 2017.
“Our relationship with Vesta is an important component of our comprehensive manufacturing plan. Vesta is an established manufacturer with proven capabilities in producing implantable silicone medical devices and components with a strong reputation for quality and safety,” said Jeffrey M. Nugent, chairman and CEO of Sientra. “We have already made significant progress with Vesta and we are confident that this ongoing relationship will enable us to uphold our promise to board-certified plastic surgeons to maintain an uninterrupted supply of our breast implant products. We believe our arrangement with Vesta will provide us a best-in-class supply chain that we can scale moving forward to support our long-term growth objectives.
“We are also looking forward to the prospects of working with Lubrizol LifeSciences and Vesta in the future on additional aesthetics technologies and innovations that can help meet unmet needs for our surgeons and their patients,” he added.